A Phase 1 Study of Concomitant High-Dose Lenalidomide and 5-Azacitidine Induction in the Treatment of AML

Leukemia - United Kingdom
doi 10.1038/leu.2012.214
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

A Phase I Study of Midostaurin and Azacitidine in Relapsed and Elderly AML Patients

Clinical Lymphoma, Myeloma and Leukemia
Cancer ResearchOncologyHematology
2015English

Daunorubicin Dose in AML Induction

Blood
BiochemistryImmunologyCell BiologyHematology
2015English

Phase I Dose Escalation Study of Bortezomib in Combination With Lenalidomide in Patients With Myelodysplastic Syndromes (MDS) and Acute Myeloid Leukemia (AML)

Leukemia Research
Cancer ResearchOncologyHematology
2013English

A Phase II Study of Oxaliplatin, Dose-Intense Capecitabine, and High-Dose Bevacizumab in the Treatment of Metastatic Colorectal Cancer

Clinical Colorectal Cancer
OncologyGastroenterology
2011English

Azacitidine and Lenalidomide as an Alternative Treatment for Refractory Acute Myeloid Leukemia: A Case Report

Sao Paulo Medical Journal
Medicine
2014English

Pretransplantation 5-Azacitidine in High-Risk Myelodysplastic Syndrome

Biology of Blood and Marrow Transplantation
TransplantationHematology
2014English

Elderly Do Benefit From Induction Chemotherapy: High Dose Mitoxantrone Based (“5+1”) Induction Chemotherapy Regimen in Newly Diagnosed Acute Myeloid Leukemia

American Journal of Hematology
Hematology
2018English

Association Between Methadone Dose and Concomitant Cocaine Use in Methadone Maintenance Treatment: A Register-Based Study

Substance Abuse: Treatment, Prevention, and Policy
PsychiatryHealth PolicyMental Health
2014English

Interest of the Association Azacitidine–lenalidomide as Frontline Therapy in High-Risk Myelodysplasia or Acute Myeloid Leukemia With Complex Karyotype

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy